With 80% of clinical trials failing to meet enrollment timelines and up to 50% of sites enrolling one or no patients at all, there are many opportunities to “rescue” studies. When timelines are at risk, data quality is suspect, and management practices are questionable, a new vendor can be brought in to rescue a study and get it back on track.
Continue reading